Lung injury may persist during the recovery period of COVID-19 as shown through imaging,
six-minute walk, and lung function tests. The pathophysiological mechanisms leading to …

COVID-19 Is characterized by an acute respiratory illness that in some patients progresses
to respiratory failure, largely demonstrating a pattern of acute respiratory distress syndrome …

Background Pulmonary involvement in COVID-19 is characterized pathologically by diffuse
alveolar damage (DAD) and thrombosis, leading to the clinical picture of Acute Respiratory …

The lung is the main affected organ in severe coronavirus disease 2019 (COVID-19) caused
by the novel coronavirus SARS-CoV-2, and lung damage is the leading cause of death in …

The pandemic respiratory illness SARS-CoV-2 has increasingly been shown to be a
systemic disease that can also have profound impacts on the cardiovascular system …

Abstract Background Infection by SARS‐CoV‐2 produces significant pulmonary pathology
including endothelial damage with resultant thrombotic events. While pathologic features …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new strain of a
Coronaviridae virus that presents 79% genetic similarity to the severe acute respiratory …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for
coronavirus disease 2019 (COVID-19). Recent data highlight a pivotal role for pulmonary …

Background Activation of inflammatory pathways promotes organ dysfunction in COVID-19.
Currently, there are reports describing lung function abnormalities in COVID-19 survivors; …

COVID-19 is an acute, complex disorder that was caused by a new β-coronavirus severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on current reports, it was …